The USFDA inspected the API manufacturing facility in Telangana between December 1 and December 12, 2025, following which a ...
MUMBAI, MAY 23 - Drugmaker Aurobindo Pharma said on Monday it has received a warning letter from the U.S. FDA, based on a field alert report for packaging and labeling compliance for unit-III, seeking ...
NEW DELHI-Aurobindo Pharma on March 17 said that the US Food and Drug Administration (USFDA) has classified one of its subsidiary units as “Official Action Indicated” following an inspection conducted ...
Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of the ...
Aurobindo Pharma on Thursday said it has received an establishment inspection report with a satisfactory Voluntary Action Indicated (VAI) classification from the US health regulator for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results